Lv41
540 积分 2022-05-09 加入
Unlocking the Potential of CAR-NK Cell Therapy: Overcoming Barriers and Challenges in the Treatment of Myeloid Malignancies
20天前
已完结
CAR-engineered NK cells versus CAR T cells in treatment of glioblastoma; strength and flaws
20天前
已完结
Engineering sonogenetic EchoBack-CAR T cells
26天前
已完结
Isolation and Functional Use of Human NKT Cells
1个月前
已完结
NKT-Licensed In Vivo Dendritic Cell-Based Immunotherapy as Cellular Immunodrugs for Cancer Treatment
1个月前
已完结
Generating allogeneic CAR-NKT cells for off-the-shelf cancer immunotherapy with genetically engineered HSP cells and feeder-free differentiation culture
1个月前
已完结
Point-of-Care CAR-T Manufacturing Solutions: Can One Model Fit All?
4个月前
已关闭
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplification
7个月前
已完结
Delivery of CD47-SIRPα checkpoint blocker by BCMA-directed UCAR-T cells enhances antitumor efficacy in multiple myeloma
7个月前
已完结
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors
7个月前
已完结
皖公网安备34019202002308
